• STAR-MS clinical trial (2020–2024): evaluation of efficacy and safety of autologous hematopoietic stem cell transplantation (aHSCT) versus high-efficacy disease-modifying therapies (Ocrelizumab, Alemtuzumab, Cladribine, Ofatumumab) in multiple sclerosis (MS), including investigation of underlying immunological mechanisms.

• Collaborations: University of Florence (2020–2021) and IRCCS Policlinico San Martino, Genoa (2019), focusing on identification of T- and B-cell subsets associated with disease activity and remission following aHSCT in aggressive MS.

• FISM Research Grant (2016–2019): study of cytotoxic T-cell responses to Epstein–Barr virus cross-reacting with myelin antigens in MS.

Visiting Research Associate, Imperial College London (2012–2016).

• Fellowships: Fondazione Italiana Sclerosi Multipla (2014); Fondazione Veronesi (2014).

• Postdoctoral Fellowship, Sapienza University of Rome (2012–2013), in collaboration with Imperial College London: multiparametric flow cytometry analysis of T-cell subsets in MS.

Postdoctoral Fellow, Fondazione IRCCS Santa Lucia, Rome (2007–2012): immunosuppressive effects of anandamide on human T lymphocytes and dendritic cells in MS.

PhD in Neurosciences, University of Rome Tor Vergata (2004–2007): CD1-restricted T-cell responses in demyelinating diseases.

Bachelor’s degree cum laude in Biological Sciences, University of Rome Tor Vergata (2004).

Facoltà

Nessuna Facoltà

Materia d'insegnamento

Immunologia

Modalità di prenotazione degli uffici

via email per definire giorno e orario del colloquio

Codice ORCID

0000-0002-2694-2392

Cosa stai cercando?

Nessun risultato per "{{ search.keyword }}"

Prova a modificare i termini di ricerca o a utilizzare parole chiave diverse.

Ricerche più frequenti

Corsi di Laurea Magistrale Corsi di Laurea Triennale Master Iscrizione

Risultati per "{{ search.keyword }}"

risultato risultati

Corsi di laurea Vai all'offerta formativa

Corso di Laurea

MASTER Vai all'offerta formativa

Master

Pagine